A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Leukemia

• Publication date

  2018-04-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41375-018-0121-1PMID 29712989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in the understanding and therapeutic management of mastocytosis

  2019cited by this paper
• Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

  2019cited by this paper
• Recent Updates on Chronic Myelomonocytic Leukemia

  2018cited by this paper
• Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients

  2018cited by this paper
• DNMT3A mutations are associated with inferior overall and leukemia‐free survival in chronic myelomonocytic leukemia

  2017cited by this paper
• Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

  2017cited by this paper
• Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance

  2017cited by this paper
• Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

  2016cited by this paper
• Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

  2016cited by this paper
• Next‐generation sequencing in systemic mastocytosis: Derivation of a mutation‐augmented clinical prognostic model for survival

  2016cited by this paper
• Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management

  2016cited by this paper
• Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

  2016cited by this paper
• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

  2016cited by this paper
• Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.

  2015cited by this paper
• Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

  2015cited by this paper
• ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

  2014cited by this paper
• Prognostic score including gene mutations in chronic myelomonocytic leukemia.

  2013cited by this paper
• Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.

  2009cited by this paper
• Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies.

  2009cited by this paper

• Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization

  2025cites this paper
• Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia

  2025cites this paper
• Newly diagnosed T-large granular lymphocyte Leukemia presenting with severe neutropenia: a case report

  2025cites this paper
• Tissue‐Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts

  2025cites this paper
• A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML

  2024cites this paper
• Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

  2024cites this paper
• Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management

  2024cites this paper
• Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis

  2024cites this paper
• How I diagnose and treat chronic myelomonocytic leukemia

  2022cites this paper
• Contemporary risk stratification and treatment of chronic myelomonocytic leukemia.

  2021cites this paper
• Phenotypic Characterization of Leukemia-Initiating Stem Cells in Chronic Myelomonocytic Leukemia

  2021cites this paper
• Mutations in chronic myelomonocytic leukemia and their prognostic relevance

  2021cites this paper
• Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis — Chronic Myelomonocytic Leukemia and Beyond

  2021cites this paper
• Chronic Myelomonocytic Leukemia Gold Jubilee

  2021cites this paper
• Chronic Myelomonocytic Leukemia: Hematopathology Perspective.

  2021cites this paper
• Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?

  2020cites this paper
• Genetic complexity of chronic myelomonocytic leukemia

  2020cites this paper
• Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019

  2020cites this paper
• Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.

  2020cites this paper
• Management of Hematologic Disease in Mastocytosis

  2019cites this paper
• Update on the pathologic diagnosis of chronic myelomonocytic leukemia

  2019cites this paper
• MDS overlap disorders and diagnostic boundaries.

  2019cites this paper
• How I investigate chronic myelomonocytic leukemia

  2019cites this paper
• Recent advances in the understanding and therapeutic management of mastocytosis

  2019cites this paper
• Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

  2019cites this paper
• Recent Updates on Chronic Myelomonocytic Leukemia

  2018cites this paper
• Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients

  2018cites this paper
• Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory‐specific incidence and prognostic impact among 348 informative cases

  2018cites this paper